16 Sep Appointment of Joint Broker
Paris, France and Camberley, UK – 16 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of Numis...
Paris, France and Camberley, UK – 16 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of Numis...
Distinguishing COVID-19 infection from other respiratory illnesses is of crucial importance in controlling the spread of the disease. This is especially true during the winter months, where there is a...
Paris, France and Camberley, UK – 4 September 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that, further to the announcement on 27...
New test differentiates COVID-19 from common winter diseases Paris, France and Camberley, UK – 27 August 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces...
Paris, France and Camberley, UK – 19 August 2020 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that its Annual General Meeting (AGM) will...
Welcome back to the latest blog! As we edge closer to the winter season. This year will be a pivotal time for testing compared to previous years. Each year during the...
Novacyt’s Near-Patient Test System (NPTS) for COVID-19 Introduction The value of testing for COVID-19 is well documented not only in the UK, but globally as we reflect on how the disease has...
Significant new opportunities for growth Paris, France and Camberley, UK – 27 July 2020 – Novacyt (EURONEXT GROWTH:ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an R&Dupdate. https://novacyt.com/wp-content/uploads/2020/07/Novacyt-RD-Update-27-07-20-ENGLISH.pdf ...
Hello! Welcome back to our latest blog. All departments have been working tirelessly to find an innovative solution following the bottle-neck of scarce raw materials that clinicians require to test. SARS-CoV-2 is...
Paris, France and Camberley, UK – 22 July 2020 – Novacyt (EURONEXT GROWTH:ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, notes the initiationof a clinical trial by Queen Mary...
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |